Drug Seems to Extend Survival for Advanced Melanoma Patients
One-third of study participants lived 5 years or more after starting treatmentContinue Reading
One-third of study participants lived 5 years or more after starting treatmentContinue Reading
Swedish study found patients were often depressed, but fewer than half got treatmentContinue Reading
Inexpensive antivirals could be a game-changer in many countries, researchers sayContinue Reading
Popular 12-step program for problem gamblers may not address related needs, research suggestsContinue Reading
Popular 12-step program for problem gamblers may not address related needs, research suggestsContinue Reading
But finding can’t show whether drugs are directly responsibleContinue Reading
Eslicarbazepine may make management easier, safer for people with the disorder, researchers sayContinue Reading
Eslicarbazepine may make management easier, safer for people with the disorder, researchers sayContinue Reading
If findings are confirmed, treatment could cut number of patients on waiting lists, researchers sayContinue Reading
Vision improvement with clemastine fumarate appears modest but results are promising, researcher saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.